CD96 also has differential immunomodulatory effects, and acts as an immunosuppressive agent in gliomas, revealing heightened expression in malignant phenotypes, with an adverse impact on overall survival, in contrast to its role in other cancers like melanoma where it is involved in activating immune responses​​. The gene discussed is CD96; the disease is central nervous system cancer.